Microsoft unveils new Surface devices

But Tuesday is all about Microsoft, which unveiled a slew of devices ahead of the holiday shopping season. Its lineup includes a new version of its desktop computer, called the Surface Studio 2, and its…

The internet industry is suing California over its…

The internet industry is suing the state of California over its days-old net neutrality law. The lawsuit, filed on Wednesday by major trade groups representing broadband companies, is the second major lawsuit filed against the…

Aston Martin falls 5% in its London IPO

Aston Martin is joining the ranks of listed automakers with an IPO that values the British company at more than $5 billion. But its first day of trading in London got off to a rocky…

SoftBank and Toyota want driverless cars to change…

SoftBank and Toyota want to change the world of transportation through autonomous vehicles and other technologies. The high-profile Japanese companies are forming a joint venture called Monet to develop businesses that will use driverless-car technology…

7 things to know before the bell

Click chart for more in-depth data. 1. The race to driverless cars: SoftBank (SFTBF) and Toyota (TM) are forming a joint venture that will use driverless-car technology to offer new services, such as mobile convenience…

Teva could be hit by huge fine on…

Was Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) part of the largest cartel in US history? US states indicted six generics companies in the US two years ago, including Teva, for price fixing. Those…

Treasury increases Jerusalems special grant

Minister of Finance Moshe Kahlon and new Jerusalem Mayor Moshe Leon have reached agreement on NIS 950 million in government support for the Jerusalem municipality's budget in 2019. The support includes an allocation for income…

Entera Bio signs $270m Amgen licensing deal

Israeli clinical-stage biopharmaceutical company Entera Bio Ltd. (Nasdaq: ENTX) announced today that it has entered into a research collaboration and license agreement with Amgen in inflammatory disease and other serious illnesses. The agreement could be…